首页 | 本学科首页   官方微博 | 高级检索  
检索        

银杏叶提取物的心肌延迟保护作用及其机制研究
引用本文:李年生,钟志莲,姜德建.银杏叶提取物的心肌延迟保护作用及其机制研究[J].中草药,2007,38(7):1046-1050.
作者姓名:李年生  钟志莲  姜德建
作者单位:1. 中南大学药学院药理学系,湖南,长沙,410078
2. 中南大学湘雅医院,检验科,湖南,长沙,410078
摘    要:目的观察银杏叶提取物(EGb761)对大鼠离体心脏心肌的延迟保护作用及其机制。方法离体大鼠心脏全心停灌缺血30min后再灌注30min产生缺血再灌损伤,观测心率(HR)、冠脉流量(CF)、左室内压(LVP)和左室内压变化最大速率( dp/dtmax),测定心肌组织中肌酸激酶(CK)释放量、心肌组织丙二醛(MDA)和一氧化氮(NO)的量。结果实验前24h单次ig给予EGb761(50或100mg/kg)可显著改善心肌缺血再灌注所致的心功能(LVP和 dp/dtmax)损伤,抑制心肌组织CK释放和MDA水平的增加以及NO水平的降低。预先给予NO合酶抑制剂L-NAME(5mg/kg)或心肌肌细胞膜ATP敏感钾通道(sarcKATP)阻断药HMR1883(3mg/kg),均可明显抑制EGb761对心肌缺血再灌注损伤的延迟保护作用。结论EGb761对缺血再灌注诱导大鼠心肌损伤具有延迟性保护作用,这一保护作用可能与增加NO合成和开放sarcKATP通道有关。

关 键 词:银杏叶提取物(EGb761)  缺血再灌注损伤  ATP敏感钾通道  一氧化氮
文章编号:0253-2670(2007)07-1046-05
收稿时间:1/8/2007 12:00:00 AM
修稿时间:2007-01-08

Delayed cardioprotection of Gingkgo biloba leaf extract and its mechanisms
Li Niansheng,Zhong Zhilian and Jiang Dejian.Delayed cardioprotection of Gingkgo biloba leaf extract and its mechanisms[J].Chinese Traditional and Herbal Drugs,2007,38(7):1046-1050.
Authors:Li Niansheng  Zhong Zhilian and Jiang Dejian
Institution:1. Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, Changsha 410078, China; 2. Clinical Laboratory, The Xiangya Hospital of Central South University, Changsha 410078, China
Abstract:Objective To observe the delayed cardioprotective effect of the extract of Gingkgo biloba leaves(EGb761)and its possible mechanisms in rats.Methods Myocardial ischemia-reperfusion(I/R)injury was induced by 30 min of global ischemia and 30 min of reperfusion in isolated rat hearts.Heart rate(HR),coronary flow(CF),left ventricular pressure(LVP),and its first derivatives( dp/dtmax)were recorded,and the releasing content of creatine kinase(CK),contents of malondialdehyde(MDA)and nitric oxide(NO)in myocardial tissues were measured.Results Single ig EGb761(50 or 100 mg/kg)at 24 h before I/R were done could significantly attenuate the damage of cardiac function(LVP and dp/dtmax)and the lowering of NO level in myocardial tissues,and inhibit the increasing in CK release and MDA level induced by I/R in myocardial tissues.The delayed cardioprotective effects of EGb761 were markedly inhibited by pretreatment with L-NAME(5 mg/kg),an inhibitor of NO synthase,or HMR1883(3 mg/kg),an antagonist of sarcolemmal ATP-sensitive potassium channels(sarcKATP).Conclusion Pretreatment with EGb761 could protect against I/R-induced myocardial injury in rats,and the delayed cardioprotection of EGb761 may be related to increasing in NO production and opening of sarcKATP.
Keywords:the extract of Gingkgo biloba leaves(EGb761)  myocardial ischemia-reperfusion injury  sarcolemmal ATP-sensitive potassium channels(sarcKATP)  nitric oxide(NO)
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中草药》浏览原始摘要信息
点击此处可从《中草药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号